In Japan, the leukemia mortality rate per 100,000 people is expected to increase slightly over the next five years, from 7.4 in 2024 to 7.7 by 2028. This indicates a minor upward trend with a steady year-on-year growth of approximately 0.1 deaths per 100,000 persons annually.
Key factors affecting these trends include the aging population and potential advancements in medical treatments. Moreover, emphasis on early diagnosis and treatment advancements could help stabilize or even improve future mortality rates. Monitoring developments in healthcare policies and technology for leukemia treatment will be crucial in shaping these outcomes.
